Wheaton J E, Lamb G C
Department of Animal Science, University of Minnesota, Twin Cities Campus, 495 Animal Science/Veterinary Medicine Building, 1988 Fitch Avenue, St. Paul, MN 55108, United States.
Anim Reprod Sci. 2007 Dec;102(3-4):208-16. doi: 10.1016/j.anireprosci.2006.11.006. Epub 2006 Nov 19.
The objective of the present study was to determine whether treatment of postpartum multiparous and primiparous anestrous beef cows with an intravaginal progesterone-releasing insert (CIDR) and PGF(2alpha), with and without the addition of GnRH or estradiol cypionate (ECP) at the time of CIDR insertion, is effective in stimulating onset of estrous cycles. Postpartum lactating Angus primiparous (n=47, 2 years of age, 495+/-6 kg) and multiparous (n=76, >or=3 years of age, 553+/-9 kg) cows were assigned by calving date to four blocks spaced 21-day apart. Cows were assigned sequentially by calving date to four treatment groups: (1) PGF(2alpha) (n=30), (2) CIDR-PGF(2alpha) (n=30), (3) GnRH-CIDR-PGF(2alpha) (n=33), and (4) ECP-CIDR-PGF(2alpha) (n=27). Intravaginal CIDR inserts were in place from days -7 to 0. A single 100 microg injection of GnRH or 2 mg ECP were administered on day -7, and 25mg PGF(2alpha) was administered on day 0. Day 0 averaged 38+/-1 day postpartum. Blood samples were collected on days -19, -9, 0, 5, 9, 12, 16, 19, 23, 26, and 30 for determination of plasma progesterone concentrations. Pre-treatment luteal activity (progesterone>or=1 ng/ml) was detected in 19% of primiparous and 8% of multiparous cows. Progesterone concentrations on day 0 were greater (P<0.001) in primiparous (3.2+/-0.3 ng/ml) than multiparous (2.0+/-0.2 ng/ml) cows. Following CIDR withdrawal, progesterone concentrations from days 5 to 30 were used to categorize response profiles as either: (1) treatment-induced onset of estrous cycles, (2) continued anestrus, or (3) spontaneous ovulation and subsequent formation of a CL. Incidence of treatment-induced onset of estrous cycles, which was defined as progesterone concentrations >or=1 ng/ml in three or more consecutive samples from days 9 to 19, was influenced by treatment and parity. Percentages of cows initiating estrous cycles were greater (P<0.001) in the three CIDR-treated groups than in the PGF(2alpha) group (55 and 8%, respectively). Percentages of cows initiating estrous cycles in the CIDR-PGF(2alpha), GnRH-CIDR-PGF(2alpha), and ECP-CIDR-PGF(2alpha) groups were 55, 58, and 52%, respectively. Incidence of treatment-induced estrous cycles in the three CIDR-treated groups of cows was greater (P=0.008) in primiparous (76%) than multiparous (43%) cows. Treatment of postpartum anestrous primiparous and multiparous beef cows with CIDR-PGF(2alpha) approximately 40-day postpartum provides an approach to increase the percentage of cows that have reinitiated estrous cycles by the start of the breeding season.
本研究的目的是确定对产后经产和初产的乏情肉用母牛,使用阴道内孕酮释放装置(CIDR)和前列腺素F2α(PGF2α)进行治疗,在插入CIDR时添加或不添加促性腺激素释放激素(GnRH)或环丙孕酮(ECP),是否能有效刺激发情周期的开始。产后泌乳的安格斯初产母牛(n = 47,2岁,495±6 kg)和经产母牛(n = 76,≥3岁,553±9 kg)按产犊日期分为4个间隔21天的组。母牛按产犊日期依次分为4个治疗组:(1)PGF2α(n = 30),(2)CIDR - PGF2α(n = 30),(3)GnRH - CIDR - PGF2α(n = 33),和(4)ECP - CIDR - PGF2α(n = 27)。阴道内CIDR装置在第 - 7天至第0天放置。在第 - 7天单次注射100μg GnRH或2mg ECP,并在第0天注射25mg PGF2α。第0天平均为产后38±1天。在第 - 19、 - 9、0、5、9、12、16、19、23、26和30天采集血样,用于测定血浆孕酮浓度。在19%的初产母牛和8%的经产母牛中检测到治疗前的黄体活性(孕酮≥1 ng/ml)。初产母牛(3.2±0.3 ng/ml)在第0天的孕酮浓度高于经产母牛(2.0±0.2 ng/ml)(P<0.001)。在取出CIDR后,将第5天至第30天的孕酮浓度用于将反应情况分类为:(1)治疗诱导的发情周期开始,(2)持续乏情,或(3)自发排卵及随后黄体的形成。治疗诱导的发情周期开始的发生率,定义为在第9天至第19天的三个或更多连续样本中孕酮浓度≥1 ng/ml,受治疗和胎次影响。三个CIDR治疗组中开始发情周期的母牛百分比高于PGF2α组(分别为55%和8%)(P<0.001)。CIDR - PGF2α、GnRH - CIDR - PGF2α和ECP - CIDR - PGF2α组中开始发情周期的母牛百分比分别为55%、58%和52%。三个CIDR治疗组的母牛中,治疗诱导的发情周期发生率在初产母牛(76%)中高于经产母牛(43%)(P = 0.008)。产后约40天对初产和经产的乏情肉用母牛用CIDR - PGF2α进行治疗,为提高到繁殖季节开始时重新开始发情周期的母牛百分比提供了一种方法。